TellWell
← Back to feed
Publications5h ago88% confidenceConfidence 88% — the share of independent, credible sources corroborating the core facts.

eQTM Atlas: New Resource Maps DNA Methylation to Gene Expression Across Tissues and Diseases

Center 100%
2 sources

Researchers have created the eQTM Atlas, a freely available web-based resource cataloging over 11 million associations between DNA methylation sites and gene expression levels across 11 tissue types and 4 disease contexts. The resource addresses a key challenge in epigenome-wide association studies (EWAS) by connecting methylation changes to specific genes rather than relying solely on physical proximity. This tool enables researchers to better interpret how DNA methylation changes affect disease and develop new hypotheses about disease mechanisms.

The eQTM Atlas integrates expression quantitative trait methylation (eQTM) data from eight cohorts, covering 173,886 unique DNA methylation sites and 20,231 genes. While epigenome-wide association studies have identified thousands of methylation sites linked to diseases and traits, interpreting their functional significance has been difficult because researchers typically assigned CpG sites to nearby genes based only on genomic location. The new Atlas solves this by providing statistically validated associations between methylation changes and actual gene expression changes. The web interface allows researchers to search by gene or methylation site, filter by tissue or disease type, visualize results through genome browsers and heatmaps, and download cohort-level data. By connecting disease-associated methylation sites to their functional gene targets, the resource should accelerate the translation of EWAS findings into biological insights and therapeutic targets.

What's missing

The study does not discuss potential limitations of the eQTM approach, such as tissue-specificity of methylation-expression relationships, the possibility of reverse causality (whether methylation changes cause expression changes or vice versa), or how results may vary across different populations or disease stages.

What different sources said

  • bioRxivCenter

    HOMED enables hierarchical and multimodal optimization of DNA methylation deconvolution across tissues

  • bioRxivCenter

    eQTM (expression quantitative trait methylation) Atlas: a comprehensive resource of over 11 million DNA methylation-gene expression associations through across 11 tissues and 4 diseases

Related

PublicationsConfidence 82% — the share of independent, credible sources corroborating the core facts.

Study Shows Statins Reduce Coenzyme Q in Brain Cells, Impairing Mitochondrial Function

A laboratory study found that statin drugs decrease coenzyme Q levels in astrocytes (brain support cells) by 30-40%, reducing their mitochondrial energy production and increasing oxidative stress. Astrocytes are critical for maintaining brain health and protecting neurons from damage. The findings suggest CoQ10 supplementation may help counteract these effects, though human clinical evidence remains limited.

1 source23m ago
PublicationsConfidence 82% — the share of independent, credible sources corroborating the core facts.

Study reveals zebrafish larvae exhibit slowly fluctuating directional swim biases driven by internal dynamics

Researchers found that 5-day-old zebrafish larvae display changing directional swim preferences over many hours even in stable environments, contrary to classical models assuming constant individual biases. Computational analysis suggests these fluctuations arise from a non-stationary Markovian process with two independent internal input streams modulating swim direction repetition. The findings suggest animals possess intrinsic mechanisms for generating behavioral variability independent of external stimuli, with implications for understanding how internal states shape adaptive behavior.

1 source23m ago
PublicationsConfidence 78% — the share of independent, credible sources corroborating the core facts.

Two Small Molecules Show Promise as Broad-Spectrum Coronavirus Inhibitors in Laboratory Study

Researchers found that sennoside A and ceftazidime, two small molecules, can inhibit RNA binding in the nucleocapsid proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV in laboratory experiments. The nucleocapsid protein is highly conserved across coronaviruses and essential for viral replication, making it a potential drug target. The findings suggest these compounds could form the basis for pan-coronavirus antiviral therapies, though further development and clinical testing would be needed.

1 source23m ago